Skip to Content

Taihe Group Inc TIHE

Morningstar Rating
$1.00 −4.00 (80.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TIHE is trading within a range we consider fairly valued.
Price
$3.32
Fair Value
$9.94
Uncertainty
Extreme
1-Star Price
$94.44
5-Star Price
$9.57
Economic Moat
Qtkct
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TIHE is a good fit for your portfolio.

Trading Information

Previous Close Price
$5.00
Day Range
$1.001.00
52-Week Range
$1.005.00
Bid/Ask
$3.30 / $70.00
Market Cap
$71.85 Mil
Volume/Avg
2 / 2

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Total Number of Employees

Comparables

Valuation

Metric
TIHE
QSI
VCYT
Price/Earnings (Normalized)
191.42
Price/Book Value
0.621.62
Price/Sales
122.384.63
Price/Cash Flow
32.22
Price/Earnings
TIHE
QSI
VCYT

Financial Strength

Metric
TIHE
QSI
VCYT
Quick Ratio
29.564.41
Current Ratio
30.655.00
Interest Coverage
−11,324.57
Quick Ratio
TIHE
QSI
VCYT

Profitability

Metric
TIHE
QSI
VCYT
Return on Assets (Normalized)
−27.45%8.19%
Return on Equity (Normalized)
−29.81%8.76%
Return on Invested Capital (Normalized)
−31.82%7.87%
Return on Assets
TIHE
QSI
VCYT
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
XzkkcbcshGqqd$231.8 Bil
Danaher Corp
DHR
CzxzmxgnsHjlkq$197.8 Bil
IQVIA Holdings Inc
IQV
BglnlxnfLdvhvd$43.7 Bil
Agilent Technologies Inc
A
FjdghfxvFbwg$40.1 Bil
IDEXX Laboratories Inc
IDXX
BqfbjqpthWfynxm$38.8 Bil
Mettler-Toledo International Inc
MTD
HmfjwqzfcDxsfqh$31.0 Bil
Icon PLC
ICLR
TmylmdjqPdybsw$26.8 Bil
Illumina Inc
ILMN
BmjvdfgkPmkmm$19.2 Bil
Waters Corp
WAT
WhcngcrlypCbd$18.9 Bil
Labcorp Holdings Inc
LH
MqlbdrfpMnskws$17.8 Bil

Sponsor Center